- Fee assured
- Verified this account
This healthcare professional let us know that they are currently available for:
- Face-to-face consultations
- Video consultations
- Phone consultations
Last updated: 12 Nov 2020
- Inflammatory bowel disease
- Video and telephone consultations
Dr Debabrata (Deb) Majumdar was appointed as Consultant Gastroenterologist at Ashford & St Peter’s Hospital in January 2014. He is currently the Hepato-biliary and Endoscopy lead in the hospital, also leading in development of Barrett’s oesophagus service and introduction of non-invasive assessment of liver disease (Fibroscan).
He has a particular interest in diagnostic and therapeutic endoscopy (gastroscopy and colonoscopy), ERCP and endoscopic ultrasound.
His clinical areas of interest include managing gastric and duodenal ulcers (and Helicobacter pylori infection), gastro-oesophageal reflux and Barrett’s oesophagus, inflammatory bowel disease (Ulcerative colitis and Crohn’s disease) and liver and pancreatic diseases.
He is a JAG (UK Joint Advisory Group on GI Endoscopy; www.thejag.org.uk) accredited Endoscopist and participates in regular audits of his endoscopy practice, aiming to provide high quality and safe endoscopy to his patients. His colonoscopy quality data (Key performance Indicators) indicate results above that required as per current UK guidelines.
He excelled in his medical training, obtaining several awards, including Honours in Physiology, Senior Prosectorship in Anatomy and Gold Medal for proficiency in MD (General Medicine).
His higher medical training was at Nottingham and Sheffield. During his training, at two of the foremost Gastroenterology and Hepatology centres in UK (including Queen’s Medical Centre, Nottingham and Royal Hallamshire Hospital, Sheffield), he was able to gain valuable and extensive knowledge in a wide range of Gastroenterology and Hepatology fields. Whilst training in Sheffield, he undertook research into the development of colon cancer in inflammatory bowel disease in association with the University of Sheffield (Molecular Gastroenterology Research Group https://www.sheffield.ac.uk/oncology-metabolism/research/surgicaloncology/research/gastro_group and Chemical Engineering department. http://www.sheffield.ac.uk/chelsi). This research led to award of MD from the University of Sheffield. He has published in several national and international peer reviewed journals. He has also presented papers (oral and poster presentations) at national and international Gastroenterology meetings (American Gastroenterology Association, United European Gastroenterology Week, British Society of Gastroenterology).
He takes an active interest in training medical doctors, both at the undergraduate and post-graduate level. He is a MRCP(UK) PACES examiner.
He has been a recipient of the prestigious BSG Travelling Fellowship to visit the Gastroenterology and Endoscopy Unit of Medical University of South Carolina. He has also visited and trained in advanced specialist endoscopy at University Hospital of Santiago de Compostela, Spain. In order to further my experience in therapeutic endosonography, I have recently obtained training in Hot Axios stent placement.
Recently he has also joined Royal Surrey County hospital to provide advanced endoscopy service. stent
Areas of interest
General gastroenterology; Altered bowel habits; diarrhoea; constipation; rectal bleeding; abdominal pain; weight loss; Heartburn and reflux disease (Gastro-oesophageal reflux); Swallowing problems (dysphagia); painful swallowing (odynophagia); Barrett's Oesophagus; Inflammatory bowel disease (IBD);
Crohn's Disease; Ulcerative colitis; Irritable bowel syndrome; IBS; Colitis; Coeliac disease; Liver disease; Hepatology; Abnormal liver function tests; Jaundice; Alcoholic liver disease; Cirrhosis; Non alcoholic fatty liver disease; Fatty liver; Autoimmune liver diseases ;Biliary and pancreatic diseases; Biliary stones; Bile duct narrowing(strictures); Pancreatitis; Pancreatic cancer; liver cancer; Stomach cancer; Oesophagus cancer; Gastric ulcer; Duodenal ulcer; vomiting; nausea;
- Ms Lisa Hardes
- BMI The Runnymede Hospital Guildford Road Ottershaw Chertsey KT16 0RQ
- 01932 645963
- 07752 282699
- 01932 325390
Anaesthetists worked with
- Dr Irfan Raza Fee Assured
- BMI Hospitals
- I Want Great Care
- Surrey Gastroenterology Consultancy Limited
Current NHS consultant posts held
Ashford St Peter's Hospitals NHS Foundation Trust
Inflammatory bowel disease, Cirrhosis
capsule endoscopy, colon cancer, portal hypertension, Helicobacter pylori, Gastric ulcers,Proteomics, biomarkers
Photography, Chess, Cricket
Senior Prosector in Anatomy
Honours in Physiology
Gold Medal in Medicine
(Additional) Languages spoken
- Bengali - Native or bilingual
- Hindi - Fluent
Oppong P, Majumdar D, Atherton J, Bebb J (2015), Helicobacter pylori infection and peptic ulcers. In Waller D G(Ed.), Gastroenterology and Nutrition: Key Articles from the Medicine journal.
•Inflammation decreases keratin level in ulcerative colitis; inadequate restoration associates with increased risk of colitis-associated cancer. BMJ Open Gastro. 2015
• Roles of keratins in colorectal epithelial function and disease. Int J Exp Pathol 2012
•Fractionation extraction and solubilisation of intermediate filaments from colorectal biopsies: description and validation of a novel technique. Electrophoresis 2012
•Helicobacter pylori infection and peptic ulcers. Medicine 2011
•Pacemaker lead-associated endocarditis and recurrent MRSA septicaemia following diagnostic upper GI endoscopy Gut 2010
•An approach to drug-induced liver disease. CME journal Gastroenterology, Hepatology & Nutrition 2007
• Lesson of the Month: Beware the eosinophils! Histopatholog 2007
•Peptic ulcers and their complications. Surgery 2006;24(3)
• Cardiac dysfunction in portal hypertension among patients with cirrhosis and non-cirrhotic portal fibrosis. J Hepatol.2003; 315-9.
• Portal pressure response to losartan compared with propranolol in patients with cirrhosis. Am J Gastroenterol. 2003:1371-6.
•Increased Mucosal Expression of Insoluble Keratins 8, 18 And 19 In Long-standing Ulcerative Colitis In Comparison To Recent-onset Ulcerative Colitis: Validation of Mass Spectrometry Data. BSG. 2015
•The fate of epithelial keratins in active ulcerative colitis. BSG. 2015
•Keratin 8 Expression Is Reduced in Active Ulcerative Colitis Relative to Proximal Inactive Mucosa. DDW 2015
•Does alteration in mucosal Keratin 8 levels, phosphorylation and relative ratio to Vimentin associate with development of colitis-associated cancer? BSG Oral presentation 2013
•Keratin expression profile in active colitis and in colitis phenotypes associated with increased cancer risk: an immunohistochemical assessment. BSG 2013 Oral presentation
•Quantitative proteomics in ulcerative colitis reveals mucosal inflammation reduces levels of keratins in the insoluble fraction of the intermediate filament proteome. DDW/BSG. Poster Of Distinction 2012
•Pillcam colon capsule is an effective tool in management of patients with suspected or known inflammatory bowel disease: preliminary results from a UK tertiary care centre. DDW 2011
Courses offered to GPs
An approach to abnormal liver function tests.
Update on Inflammatory bowel disease
Update on Non Alcoholic Fatty Liver Disease
Update on IBS
Approach to Gastro-oesophageal reflux
- MBBS(Honsours.) University of Calcutta 1997
- MD(Medicine), Gold Medalist University of Calcutta 2003
- MD(Research) University of Sheffield 2017
- FRCP Royal College of Physicians London 2017
Reference number 6057762
Affiliations / memberships
British Medical Association
- B M I Mount Alvernia Hospital 46 Harvey...
- 18:00 - 21:00
- 01932 645963
- BMI The Runnymede Hospital Guildford...
- 16:00 - 20:00
- 01932 645963
- BMI The Runnymede HospitalGuildford...
- 17:00 - 19:00
- 01932 645963
- Nuffield Woking Hospital, Shores Road...
- 18:00 - 20:00
- 01932 645963
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details